Cross-transmission is not the source of new Mycobacterium abscessus infections in a multi-centre cohort of cystic fibrosis patients
Preprint
Abstract
Background: Mycobacterium abscessus is an extensively drug resistant pathogen that causes pulmonary disease particularly in cystic fibrosis (CF) patients. Identifying direct patient-to-patient transmission of M. abscessus is critically important in directing infection control policy for the management of risk in CF patients. A variety of clinical labs have used molecular epidemiology to investigate transmission. However there is still conflicting evidence as to how M. abscessus is acquired and whether cross-transmission occurs. Recently labs have applied whole-genome sequencing (WGS) to investigate this further and in this study we investigate whether WGS can reliably identify cross-transmission in M. abscessus . Methods: We retrospectively sequenced the whole genomes of 145 M. abscessus isolates from 62 patients seen at four hospitals in two countries over 16 years. Results: We have shown that a comparison of a fixed number of core single nucleotide variants (SNVs) alone cannot be used to infer cross-transmission in M. abscessus but does provide enough information to replace multiple existing molecular assays. We detected one episode of possible direct patient-to-patient transmission in a sibling pair. We found that patients acquired unique M. abscessus strains even after spending considerable time on the same wards with other M. abscessus positive patients. Conclusions: This novel analysis has demonstrated that the majority of patients in this study have not acquired M. abscessus through direct patient-patient transmission or a common reservoir. Tracking transmission using WGS will only realise its full potential with proper environmental screening as well as patient sampling. Key points: Whole genome sequencing should replace current molecular typing used routinely in clinical microbiology laboratories. Patient-to-patient spread of M. abscessus is not common. Environmental screening may provide a better understanding acquisition of M. abscessus infections.Keywords
All Related Versions
- Published version: Clinical Infectious Diseases, 70 (9), 1855.
This publication has 29 references indexed in Scilit:
- Genomic reconnaissance of clinical isolates of emerging human pathogen Mycobacterium abscessus reveals high evolutionary potentialScientific Reports, 2014
- Multilocus sequence typing scheme for the Mycobacterium abscessus complexResearch in Microbiology, 2014
- RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogeniesBioinformatics, 2014
- Phylogenomics of Brazilian epidemic isolates of Mycobacterium abscessus subsp. bolletii reveals relationships of global outbreak strainsInfection, Genetics and Evolution, 2013
- Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort studyThe Lancet, 2013
- Paediatric lung transplant outcomes vary withMycobacterium abscessuscomplex speciesEuropean Respiratory Journal, 2013
- Molecular Fingerprinting of Mycobacterium abscessus Strains in a Cohort of Pediatric Cystic Fibrosis PatientsJournal of Clinical Microbiology, 2012
- Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortalityThe Journal of Heart and Lung Transplantation, 2011
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantationThorax, 2006